These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35011410)

  • 1. Evaluation of Virtual Screening Strategies for the Identification of γ-Secretase Inhibitors and Modulators.
    Ioppolo A; Eccles M; Groth D; Verdile G; Agostino M
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of High-affinity Small Molecules Targeting Gamma Secretase for the Treatment of Alzheimer's Disease.
    Ali MA; Vuree S; Goud H; Hussain T; Nayarisseri A; Singh SK
    Curr Top Med Chem; 2019; 19(13):1173-1187. PubMed ID: 31244427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and mechanism of γ-secretase modulators for Alzheimer's disease.
    Crump CJ; Johnson DS; Li YM
    Biochemistry; 2013 May; 52(19):3197-216. PubMed ID: 23614767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. gamma-Secretase as a therapeutic target in Alzheimer's disease.
    Guardia-Laguarta C; Pera M; Lleó A
    Curr Drug Targets; 2010 Apr; 11(4):506-17. PubMed ID: 20015011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-secretase inhibition and modulation for Alzheimer's disease.
    Wolfe MS
    Curr Alzheimer Res; 2008 Apr; 5(2):158-64. PubMed ID: 18393800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore based 3D-QSAR modeling, virtual screening and docking for identification of potential inhibitors of β-secretase.
    Palakurti R; Vadrevu R
    Comput Biol Chem; 2017 Jun; 68():107-117. PubMed ID: 28288354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γ-Secretase inhibitors and modulators.
    Golde TE; Koo EH; Felsenstein KM; Osborne BA; Miele L
    Biochim Biophys Acta; 2013 Dec; 1828(12):2898-907. PubMed ID: 23791707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes.
    Imbimbo BP; Giardina GA
    Curr Top Med Chem; 2011; 11(12):1555-70. PubMed ID: 21510832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of gamma-secretase on substrates other than APP.
    Lleó A
    Curr Top Med Chem; 2008; 8(1):9-16. PubMed ID: 18220928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer's Therapeutics.
    Mouchlis VD; Melagraki G; Zacharia LC; Afantitis A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma-Secretase modulators.
    Wolfe MS
    Curr Alzheimer Res; 2007 Dec; 4(5):571-3. PubMed ID: 18220525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. γ-Secretase Inhibitors and Modulators Induce Distinct Conformational Changes in the Active Sites of γ-Secretase and Signal Peptide Peptidase.
    Gertsik N; Chau DM; Li YM
    ACS Chem Biol; 2015 Aug; 10(8):1925-31. PubMed ID: 26030233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and mechanism of the γ-secretase intramembrane protease complex.
    Wolfe MS; Miao Y
    Curr Opin Struct Biol; 2022 Jun; 74():102373. PubMed ID: 35461161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. γ-secretase substrates and their implications for drug development in Alzheimer's disease.
    Lleó A; Saura CA
    Curr Top Med Chem; 2011; 11(12):1513-27. PubMed ID: 21510835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer's disease: prospects, limitations and strategies.
    Evin G; Sernee MF; Masters CL
    CNS Drugs; 2006; 20(5):351-72. PubMed ID: 16696577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interacting with γ-secretase for treating Alzheimer's disease: from inhibition to modulation.
    Panza F; Frisardi V; Solfrizzi V; Imbimbo BP; Logroscino G; Santamato A; Greco A; Seripa D; Pilotto A
    Curr Med Chem; 2011; 18(35):5430-47. PubMed ID: 22087836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition and modulation of gamma-secretase for Alzheimer's disease.
    Wolfe MS
    Neurotherapeutics; 2008 Jul; 5(3):391-8. PubMed ID: 18625450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-secretase inhibitors for Alzheimer's disease: identification using pharmacoinformatics.
    Islam MA; Pillay TS
    J Biomol Struct Dyn; 2019 Feb; 37(2):503-522. PubMed ID: 29388503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1.
    Wu F; Schweizer C; Rudinskiy N; Taylor DM; Kazantsev A; Luthi-Carter R; Fraering PC
    FASEB J; 2010 Jul; 24(7):2464-74. PubMed ID: 20237298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics simulation study reveals potential substrate entry path into γ-secretase/presenilin-1.
    Kong R; Chang S; Xia W; Wong ST
    J Struct Biol; 2015 Aug; 191(2):120-9. PubMed ID: 26142917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.